Visions of Cannabis Control argues that cannabis prohibition is the result of moral panic that has been instigated, perpetuated, and sustained in ways that are difficult to dislodge. The book documents the history of these cannabis policies and explores the impact of issues such as racism, labelling, and stigmatization. Stan Cohen argued that reforms designed to replace carceral tendencies within correctional institutions can instead extend such approaches into our communities. The idea that criminal justice reforms often reproduce what they were intended to disrupt can be applied to the cannabis revolution currently underway around the world. Racial disparities in arrests persist, exacerbated by laws that make it legal to possess cannabis but illegal to consume it anywhere but in your home. In this book, the authors argue that too often, cannabis liberalization comes at the cost of expanding paternalistic public health models and abstention-based diversion programs. The goal of dismantling and disrupting illicit markets has undermined onerous regulations, anaemic marketing efforts, and failure to promote consumer-centred approaches. Emphasizing public health goals ahead of market conditions complicates legal cannabis as an industry. To understand the future of cannabis policy, Visions of Cannabis Control examines the experience of six countries and several US states through the lens of criminological theory, recent research, and practice. The book presents several solutions for responsible regulation concluding that sustaining reform will require a more inclusive approach ensuring those affected by cannabis policies are consulted, respected, and involved.

"This book does not take a position on whether expanded legal use of non-medical cannabis should continue. It seeks to provide a consolidated source for the evidence, issues, challenges, and experiences with legalized cannabis for non-medical use and the lessons learned from America's long history with alcohol and tobacco control. It seeks to provide guidance for those who are and will continue to be in positions to struggle with the issue of cannabis control"--

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

From the local to the global, the governance of illegal drug use is becoming increasingly fragmented. In some contexts, prohibitive regimes are being transformed or replaced, while in others there are renewed commitments to criminalized control. But what gives rise to convergence and divergence in processes of policy making, both across different countries as well as within them? Based upon empirical qualitative research with 'elite' insiders, David Brewster explores a diverse range of cannabis policy approaches across the globe. His original analysis reveals the factors which facilitate or hinder punitive or liberalising tendencies in cannabis policy processes, concluding with future directions for policy making and comparative criminology.

Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a recent Institute of Medicine study on this important issue, interpreting them for a general audience. Marijuana As Medicine? provides patientsâ€"as well as the people who care for themâ€"with a foundation for making decisions about their own health care. This empowering volume examines several key points, including: Whether marijuana can relieve a variety of symptoms, including pain, muscle spasticity, nausea, and appetite loss. The dangers of smoking marijuana, as well as the effects of its active chemical components on the immune system and on psychological health. The potential use of marijuana-based medications on symptoms of AIDS, cancer, multiple sclerosis, and several other specific disorders, in comparison with existing treatments. Marijuana As Medicine? introduces readers to the active compounds in marijuana. These include the principal ingredient in Marinol, a legal medication. The authors also discuss the prospects for developing other drugs derived from marijuana's active ingredients. In addition to providing an up-to-date review of the science behind the medical marijuana debate, Mack and Joy also answer common questions about the legal status of marijuana, explaining the conflict between state and federal law regarding its medical use. Intended primarily as an aid to patients and caregivers, this book objectively presents critical information so that it can be used to make responsible health care decisions. Marijuana As Medicine? will also be a valuable resource for policymakers, health care providers, patient counselors, medical faculty and studentsâ€"in short, anyone who wants to learn more about this important issue.

This book emphasizes concepts and methods for solving problems that occur through the interaction of the eyes and vision of people with their environment. Student clinicians will learn to assess their patient's visual tasks, visual environments, and visual performance needs in order to provide quality eye care.

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.